EU Industrial Sovereignty at Risk Five Sectors Critically Dependent on China Gold Mining Sectors Q1 Earnings Suggest Bullish Momentum May Persist Silver Price Outlook Could the Metal Surpass 100 in the Next Decade Inflation Strains Holiday Weekend Budgets as Travel Recreation and Food Prices Rise Most Applied Materials Reports Quarterly Revenue Above Market Expectations Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Key Market Moves to Watch IMPPP Q1 2026 Earnings Preferred EPS Surges Past Estimates on Strong Operating Performance INFQ Q1 2026 Earnings Loss Per Share Widens Stock Surges on No Estimate Comparison MMYT Q1 2026 Earnings EPS Miss Sends Stock Lower Despite Strong Travel Demand Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS IART Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain MS Q1 2026 Earnings Earnings Beat by 1092 as EPS Surges to 343 Cohen Steers LDP Holds Steady Near Support Amid Preferred Income Stability Primoris Services Corporation PRIM Slips 3 as Infrastructure Stock Faces Resistance SiriusPoint Ltd SPNT Declines 2 as Sector Headwinds Test Key Support Gabelli MultiMedia Trust GGT Holds Steady Near Support as Consolidation Continues REE Automotive Bounces from Support Tests Resistance at 046 Booking Holdings Launches Unified BKNG Ads Platform to Streamline Advertising Across Brands YETI Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher BWNB Senior Notes Hold Steady Near Par as Support and Resistance Levels Tighten COYA Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Rises on Efficiency Gains TALK Q1 2026 Earnings Significant EPS Miss Amid Operational Uncertainty Xtant Medical Holdings Inc XTNT Q1 2026 Earnings EPS Misses Estimates Amidst Narrow Loss AB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds PBF Energy Q1 2026 Earnings Refining Headwinds Drive WiderThanExpected Loss MHO Q1 2026 Earnings EPS Slightly Beats Estimate Stock Holds Steady SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment